226 related articles for article (PubMed ID: 15204165)
21. The use of imiquimod 5% cream for the treatment of superficial basal cell carcinomas in a basal cell nevus syndrome patient.
Kagy MK; Amonette R
Dermatol Surg; 2000 Jun; 26(6):577-8; discussion 578-9. PubMed ID: 10848940
[TBL] [Abstract][Full Text] [Related]
22. Letter: Imiquimod 5% cream as adjunctive therapy for primary, solitary, nodular basal cell carcinomas before Mohs micrographic surgery: a randomized, double-blind, vehicle-controlled study.
Moehrle M; Breuninger H; Schippert W; Häfner HM
Dermatol Surg; 2010 Mar; 36(3):428-30. PubMed ID: 20402949
[No Abstract] [Full Text] [Related]
23. Role of imiquimod in skin cancer treatment.
Urosevic M; Dummer R
Am J Clin Dermatol; 2004; 5(6):453-8. PubMed ID: 15663342
[TBL] [Abstract][Full Text] [Related]
24. Imiquimod-induced vitiligo after treatment of nodular basal cell carcinoma.
Gowda S; Tillman DK; Fitzpatrick JE; Gaspari AA; Goldenberg G
J Cutan Pathol; 2009 Aug; 36(8):878-81. PubMed ID: 19586497
[TBL] [Abstract][Full Text] [Related]
25. [Imiquimod cream. A cream to use with precaution].
Taeron C
Rev Infirm; 2010 Jun; (161):47-9. PubMed ID: 20536098
[No Abstract] [Full Text] [Related]
26. Successful treatment of basal cell carcinomas in a nevoid basal cell carcinoma syndrome with topical 5% imiquimod.
Stockfleth E; Ulrich C; Hauschild A; Lischner S; Meyer T; Christophers E
Eur J Dermatol; 2002; 12(6):569-72. PubMed ID: 12459530
[TBL] [Abstract][Full Text] [Related]
27. New cream to treat skin cancer? [news].
Mayo Clin Health Lett; 2001 Mar; 19(3):4. PubMed ID: 11242841
[No Abstract] [Full Text] [Related]
28. Use of 5% imiquimod cream in the treatment of facial basal cell carcinoma: a 3-year retrospective follow-up study.
Vun Y; Siller G
Australas J Dermatol; 2006 Aug; 47(3):169-71. PubMed ID: 16866996
[TBL] [Abstract][Full Text] [Related]
29. Sequential treatment of giant basal cell carcinomas.
Madan V; West CA; Murphy JV; Lear JT
J Plast Reconstr Aesthet Surg; 2009 Oct; 62(10):e368-72. PubMed ID: 18572004
[TBL] [Abstract][Full Text] [Related]
30. Open study of the efficacy and mechanism of action of topical imiquimod in basal cell carcinoma.
Vidal D; Matías-Guiu X; Alomar A
Clin Exp Dermatol; 2004 Sep; 29(5):518-25. PubMed ID: 15347339
[TBL] [Abstract][Full Text] [Related]
31. In vivo characterization of the inflammatory infiltrate and apoptotic status in imiquimod-treated basal cell carcinoma.
De Giorgi V; Salvini C; Chiarugi A; Paglierani M; Maio V; Nicoletti P; Santucci M; Carli P; Massi D
Int J Dermatol; 2009 Mar; 48(3):312-21. PubMed ID: 19261026
[TBL] [Abstract][Full Text] [Related]
32. Peculiar clinical and dermoscopic remission pattern following imiquimod therapy of basal cell carcinoma in seborrhoeic areas of the face.
Diluvio L; Campione E; Paternò EJ; Orlandi A; Terrinoni A; Chimenti S
J Dermatolog Treat; 2009; 20(2):124-9. PubMed ID: 18991155
[TBL] [Abstract][Full Text] [Related]
33. Long-Term Follow-Up Results of Topical Imiquimod Treatment in Basal Cell Carcinoma.
Bostanci S; Kocyigit P; Vural S; Heper AO; Botsali A
Dermatol Surg; 2018 Jan; 44(1):36-41. PubMed ID: 29016542
[TBL] [Abstract][Full Text] [Related]
34. Topical imiquimod treatment for nodular basal cell carcinomas: an open-label series.
Huber A; Huber JD; Skinner RB; Kuwahara RT; Haque R; Amonette RA
Dermatol Surg; 2004 Mar; 30(3):429-30. PubMed ID: 15008876
[TBL] [Abstract][Full Text] [Related]
35. Imiquimod and pulmonary embolism: a case report.
Leroy B; Richez A; Wolf F; Descotes J; Vial T
Therapie; 2014; 69(2):180-1. PubMed ID: 24926639
[TBL] [Abstract][Full Text] [Related]
36. 5% imiquimod cream and reflectance-mode confocal microscopy as adjunct modalities to Mohs micrographic surgery for treatment of basal cell carcinoma.
Torres A; Niemeyer A; Berkes B; Marra D; Schanbacher C; González S; Owens M; Morgan B
Dermatol Surg; 2004 Dec; 30(12 Pt 1):1462-9. PubMed ID: 15606733
[TBL] [Abstract][Full Text] [Related]
37. Treatment of various types of basal cell carcinoma with topical 5% imiquimod in the elderly who refused surgical intervention: a case series.
Kaçar SD; Özuğuz P; Erkan F; Karaca Ş
J Dermatolog Treat; 2015 Apr; 26(2):165-7. PubMed ID: 24731081
[TBL] [Abstract][Full Text] [Related]
38. Two-year interim results from a 5-year study evaluating clinical recurrence of superficial basal cell carcinoma after treatment with imiquimod 5% cream daily for 6 weeks.
Quirk C; Gebauer K; Owens M; Stampone P
Australas J Dermatol; 2006 Nov; 47(4):258-65. PubMed ID: 17034468
[TBL] [Abstract][Full Text] [Related]
39. Successful treatment of basal cell carcinoma on the face with imiquimod 5% cream.
Oster-Schmidt C; Altmeyer P; Stücker M
Acta Derm Venereol; 2002; 82(6):477. PubMed ID: 12575864
[No Abstract] [Full Text] [Related]
40. Photodynamic therapy for basal cell carcinoma.
Fargnoli MC; Peris K
Future Oncol; 2015 Nov; 11(22):2991-6. PubMed ID: 26550910
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
